Trials / Recruiting
RecruitingNCT03346772
Study of Immune Responses to Influenza Vaccination
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peripheral blood drawn at pre-defined intervals in order to study the lymphocyte responses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Influenza vaccination | Adults will receive one intramuscular dose of seasonal quadrivalent inactivated influenza vaccine, as indicated for standard of care. |
Timeline
- Start date
- 2017-10-20
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2017-11-17
- Last updated
- 2025-08-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03346772. Inclusion in this directory is not an endorsement.